These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 15035104

  • 1. [Possible role of RANKL in bone resorption].
    Udagawa N, Nakamura M, Takahashi N.
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():97-101. PubMed ID: 15035104
    [No Abstract] [Full Text] [Related]

  • 2. [OPG(osteoprotegerin)/OCIF(osteoclastogenesis inhibitory factor)].
    Inoue D.
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():102-6. PubMed ID: 15035105
    [No Abstract] [Full Text] [Related]

  • 3. [Regulatory mechanism of osteoclast differentiation and function].
    Okumura S, Udagawa N, Takahashi N.
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():90-6. PubMed ID: 15035103
    [No Abstract] [Full Text] [Related]

  • 4. [Possible role of receptor activator of NF-kappa B ligand(RANKL) in osteoclast differentiation and function].
    Udagawa N, Takahashi N.
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():672-8. PubMed ID: 11979968
    [No Abstract] [Full Text] [Related]

  • 5. [LPS].
    Miyaura C.
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():116-9. PubMed ID: 15035108
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Crosstalk between the immune and skeletal system].
    Takayanagi H.
    Ryumachi; 2003 Oct; 43(4):624-31. PubMed ID: 14598653
    [No Abstract] [Full Text] [Related]

  • 8. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R, Morko J, Alatalo SL, NicAmhlaoibh R, Risteli J, Laitala-Leinonen T, Vuorio E.
    Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Recent advances in research of bone resorption].
    Inoue D.
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():48-56. PubMed ID: 11979946
    [No Abstract] [Full Text] [Related]

  • 11. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.
    Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T.
    Nature; 2000 Nov 30; 408(6812):600-5. PubMed ID: 11117749
    [Abstract] [Full Text] [Related]

  • 12. Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation.
    Glass DA, Karsenty G.
    Ann N Y Acad Sci; 2006 Apr 30; 1068():117-30. PubMed ID: 16831912
    [Abstract] [Full Text] [Related]

  • 13. Loss of chaotic trabecular structure in OPG-deficient juvenile Paget's disease patients indicates a chaogenic role for OPG in nonlinear pattern formation of trabecular bone.
    Salmon P.
    J Bone Miner Res; 2004 May 30; 19(5):695-702. PubMed ID: 15068491
    [Abstract] [Full Text] [Related]

  • 14. [Stimulator of bone resorption interleukin-1, interleukin-6 and gp-130 cytokine family].
    Suzuki Y.
    Nihon Rinsho; 2004 Feb 30; 62 Suppl 2():107-11. PubMed ID: 15035106
    [No Abstract] [Full Text] [Related]

  • 15. Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption.
    Aubin JE, Bonnelye E.
    Medscape Womens Health; 2000 Mar 30; 5(2):5. PubMed ID: 10792853
    [Abstract] [Full Text] [Related]

  • 16. Osteoprotegerin and inflammation.
    Saidenberg Kermanac'h N, Bessis N, Cohen-Solal M, De Vernejoul MC, Boissier MC.
    Eur Cytokine Netw; 2002 Mar 30; 13(2):144-53. PubMed ID: 12101070
    [Abstract] [Full Text] [Related]

  • 17. [Osteoprotegerin ligand and osteoprotegerin: new concepts of the pathogenesis and therapy of metabolic bone diseases].
    Hofbauer LC, Heufelder AE.
    Dtsch Med Wochenschr; 2001 Feb 09; 126(6):145-50. PubMed ID: 11233883
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.